Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity (IT-MATTERS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01265849
Recruitment Status : Active, not recruiting
First Posted : December 23, 2010
Last Update Posted : March 19, 2021
Sponsor:
Collaborators:
Teva Branded Pharmaceutical Products R&D, Inc.
Orient Europharma Co., Ltd.
Information provided by (Responsible Party):
CEL-SCI Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : May 15, 2020
Estimated Study Completion Date : April 15, 2021